Wayne Koff, Ph.D., is Chairman of MyImmunome, Inc. a biotechnology company which aims to bring comprehensive immune profiling directly to the consumer, and an advisor to multiple biotechnology companies and non-governmental organizations at the nexus of human immunology, vaccine R&D, and artificial intelligence. Previously, Dr. Koff was the founding President and CEO of the Human Immunome Project (formerly known as the Human Vaccines Project), a public-private partnership with the goal of creating AI models of the human immune system to accelerate development of vaccines and immunotherapies for major infectious and non-communicable diseases. In recognition of his achievements, in 2019, Dr. Koff was named by Foreign Policy, "as one of the100 thinkers and doers who had a profound impact on the planet in the last 12 months".